» Articles » PMID: 2422813

Characterization of Glycoproteins of Viruses Causing Hemorrhagic Fever with Renal Syndrome (HFRS) Using Monoclonal Antibodies

Overview
Journal Virology
Specialty Microbiology
Date 1986 Jun 1
PMID 2422813
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Viruses causing hemorrhagic fever with renal syndrome (HFRS) encode two glycoproteins, G1 and G2. For determination of the biological functions of these glycoproteins, we isolated 15 hybridomas secreting monoclonal antibodies directed against the glycoproteins of the B-1 and Hantaan viruses (HV). From results of neutralizing and hemagglutination inhibition (HI) tests, and studies on the antigenic reactivities of the antibodies with other HV-related viruses by immunofluorescence, we classified these hybridoma clones into two groups producing antibodies to the G1 proteins of the B-1 virus, six groups producing antibodies to G2 proteins of the B-1 virus, and four groups producing antibodies to the G2 protein of HV. Of the antibodies to G2 produced by 12 clones, groups A and B had high HI activity with HV-related virus cross-reactivity and moderate neutralizing activity, group C had moderate HI activity with virus specificity but low neutralizing activity, group G had high neutralizing activity and low HI activity, and five other groups had little or no HI or neutralizing activity. Group A reacting with G1 protein had low level of both neutralizing and HI activity, while group B had no HI activity. One clone of monoclonal antibody had high neutralizing activity and no HI activity, but it did not react with either polypeptide by immunoprecipitation followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or by the immunoblotting method. These data suggest that both glycoproteins are the targets of neutralizing antibodies. Furthermore, the results indicate that the antigenic determinants with hemagglutination activity are mainly on the G2 protein, and that the domains related to neutralizing activity and to HI activity are separate.

Citing Articles

Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention.

Sehgal A, Mehta S, Sahay K, Martynova E, Rizvanov A, Baranwal M Viruses. 2023; 15(2).

PMID: 36851775 PMC: 9966805. DOI: 10.3390/v15020561.


Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein.

Rissanen I, Stass R, Krumm S, Seow J, Hulswit R, Paesen G Elife. 2020; 9.

PMID: 33349334 PMC: 7755396. DOI: 10.7554/eLife.58242.


Progress on the Prevention and Treatment of Hantavirus Disease.

Brocato R, Hooper J Viruses. 2019; 11(7).

PMID: 31277410 PMC: 6669544. DOI: 10.3390/v11070610.


Comparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodies.

Li W, Cao S, Zhang Q, Li J, Zhang S, Wu W Virol J. 2017; 14(1):133.

PMID: 28720142 PMC: 5516384. DOI: 10.1186/s12985-017-0799-0.


Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Haese N, Brocato R, Henderson T, Nilles M, Kwilas S, Josleyn M PLoS Negl Trop Dis. 2015; 9(6):e0003803.

PMID: 26046641 PMC: 4457835. DOI: 10.1371/journal.pntd.0003803.